Dipal Doshi
Chief Executive Officer, Director
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Entrada Therapeutics, Inc. (TRDA) | Chief Executive Officer | $635,000 | $3,837,737 |
| 2024 | Entrada Therapeutics, Inc. (TRDA) | Chief Executive Officer | $610,000 | $3,891,503 |
| 2023 | Entrada Therapeutics, Inc. (TRDA) | Chief Executive Officer | $585,000 | $3,735,466 |
| 2022 | Entrada Therapeutics, Inc. (TRDA) | Chief Executive Officer | $565,000 | $3,491,063 |
| 2021 | Entrada Therapeutics, Inc. (TRDA) | President and Chief Executive Officer | $425,057 | $5,530,399 |
Earnings-call appearances
-
Entrada Therapeutics, Inc. Q1 FY2026 Earnings Call2026-05-07
Entrada Therapeutics, Inc. (TRDA)